489
Views
62
CrossRef citations to date
0
Altmetric
Research Article

Formulation and evaluation of microemulsion-based in situ ion-sensitive gelling systems for intranasal administration of curcumin

, , , &
Pages 831-840 | Received 01 Jun 2012, Accepted 30 Jul 2012, Published online: 31 Aug 2012

References

  • Basu S, Bandyopadhyay AK. (2010). Development and characterization of mucoadhesive in situ nasal gel of midazolam prepared with Ficus carica mucilage. AAPS PharmSciTech, 11, 1223–1231.
  • Cai Z, Song X, Sun F, Yang Z, Hou S, Liu Z. (2011). Formulation and evaluation of in situ gelling systems for intranasal administration of gastrodin. AAPS PharmSciTech, 12, 1102–1109.
  • Cao SL, Chen E, Zhang QZ, Jiang XG. (2007). A novel nasal delivery system of a Chinese traditional medicine, Radix Bupleuri, based on the concept of ion-activated in situ gel. Arch Pharm Res, 30, 1014–1019.
  • Cao SL, Ren XW, Zhang QZ, Chen E, Xu F, Chen J, Liu LC, Jiang XG. (2009). In situ gel based on gellan gum as new carrier for nasal administration of mometasone furoate. Int J Pharm, 365, 109–115.
  • Cao SL, Zhang QZ, Jiang XG. (2007). Preparation of ion-activated in situ gel systems of scopolamine hydrobromide and evaluation of its antimotion sickness efficacy. Acta Pharmacol Sin, 28, 584–590.
  • Chen J, Zhang C, Liu Q, Shao X, Feng C, Shen Y, Zhang Q, Jiang X. (2012). Solanum tuberosum lectin-conjugated PLGA nanoparticles for nose-to-brain delivery: in vivo and in vitro evaluations. J Drug Target, 20, 174–184.
  • Cho HJ, Ku WS, Termsarasab U, Yoon I, Chung CW, Moon HT, Kim DD. (2012). Development of udenafil-loaded microemulsions for intranasal delivery: in vitro and in vivo evaluations. Int J Pharm, 423, 153–160.
  • Cui J, Yu B, Zhao Y, Zhu W, Li H, Lou H, Zhai G. (2009). Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems. Int J Pharm, 371, 148–155.
  • Dayal P, Pillay V, Babu RJ, Singh M. (2005). Box-Behnken experimental design in the development of a nasal drug delivery system of model drug hydroxyurea: characterization of viscosity, in vitro drug release, droplet size, and dynamic surface tension. AAPS PharmSciTech, 6, E573–E585.
  • Dhule SS, Penfornis P, Frazier T, Walker R, Feldman J, Tan G, He J, Alb A, John V, Pochampally R. (2012). Curcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma. Nanomedicine, 8, 440–451.
  • Furubayashi T, Inoue D, Kamaguchi A, Higashi Y, Sakane T. (2007). Influence of formulation viscosity on drug absorption following nasal application in rats. Drug Metab Pharmacokinet, 22, 206–211.
  • Gao Y, Wang Y, Ma Y, Yu A, Cai F, Shao W, Zhai G. (2009). Formulation optimization and in situ absorption in rat intestinal tract of quercetin-loaded microemulsion. Colloids Surf B Biointerfaces, 71, 306–314.
  • Illum L. (2000). Transport of drugs from the nasal cavity to the central nervous system. Eur J Pharm Sci, 11, 1–18.
  • Jansson B, Hägerström H, Fransén N, Edsman K, Björk E. (2005). The influence of gellan gum on the transfer of fluorescein dextran across rat nasal epithelium in vivo. Eur J Pharm Biopharm, 59, 557–564.
  • Krauland AH, Leitner VM, Bernkop-Schnürch A. (2003). Improvement in the in situ gelling properties of deacetylated gellan gum by the immobilization of thiol groups. J Pharm Sci, 92, 1234–1241.
  • Kumar M, Misra A, Babbar AK, Mishra AK, Mishra P, Pathak K. (2008). Intranasal nanoemulsion based brain targeting drug delivery system of risperidone. Int J Pharm, 358, 285–291.
  • Li X, Zhang Y, Fan Y, Zhou Y, Wang X, Fan C, Liu Y, Zhang Q. (2011). Preparation and evaluation of novel mixed micelles as nanocarriers for intravenous delivery of propofol. Nanoscale Res Lett, 6, 275.
  • Li X, Zheng L, Jiang T, Wang Z, Wang S. (2010). Preparation of curcumin microemulsion-based gel for nasal use and determination of its properties. J Shenyang Pharm Univ, 27, 98.
  • Liu CH, Chang FY. (2011). Development and characterization of eucalyptol microemulsions for topic delivery of curcumin. Chem Pharm Bull, 59, 172–178.
  • Lorin MI, Gaerlan PF, Mandel ID. (1972). Quantitative composition of nasal secretions in normal subjects. J Lab Clin Med, 80, 275–281.
  • Ma Z, Shayeganpour A, Brocks DR, Lavasanifar A, Samuel J. (2007). High-performance liquid chromatography analysis of curcumin in rat plasma: application to pharmacokinetics of polymeric micellar formulation of curcumin. Biomed Chromatogr, 21, 546–552.
  • Majithiya RJ, Ghosh PK, Umrethia ML, Murthy RS. (2006). Thermoreversible-mucoadhesive gel for nasal delivery of sumatriptan. AAPS PharmSciTech, 7, 67.
  • Mao C, Wan J, Chen H, Xu H, Yang X. (2009). Emulsifiers’ composition modulates venous irritation of the nanoemulsions as a lipophilic and venous irritant drug delivery system. AAPS PharmSciTech, 10, 1058–1064.
  • Miyazaki S, Aoyama H, Kawasaki N, Kubo W, Attwood D. (1999). In situ-gelling gellan formulations as vehicles for oral drug delivery. J Control Release, 60, 287–295.
  • Mourtas S, Canovi M, Zona C, Aurilia D, Niarakis A, La Ferla B, Salmona M, Nicotra F, Gobbi M, Antimisiaris SG. (2011). Curcumin-decorated nanoliposomes with very high affinity for amyloid-β1-42 peptide. Biomaterials, 32, 1635–1645.
  • Piao HM, Balakrishnan P, Cho HJ, Kim H, Kim YS, Chung SJ, Shim CK, Kim DD. (2010). Preparation and evaluation of fexofenadine microemulsions for intranasal delivery. Int J Pharm, 395, 309–316.
  • Quan ZZ, Bin L. (2001). Advance in microemulsions as a vehicle of drug delivery system. Chin J Pharm, 32, 139–142.
  • Roney C, Kulkarni P, Arora V, Antich P, Bonte F, Wu A, Mallikarjuana NN, Manohar S, Liang HF, Kulkarni AR, Sung HW, Sairam M, Aminabhavi TM. (2005). Targeted nanoparticles for drug delivery through the blood-brain barrier for Alzheimer’s disease. J Control Release, 108, 193–214.
  • Rupenthal ID, Green CR, Alany RG. (2011). Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 1: physicochemical characterisation and in vitro release. Int J Pharm, 411, 69–77.
  • Sasaki H, Sunagawa Y, Takahashi K, Imaizumi A, Fukuda H, Hashimoto T, Wada H, Katanasaka Y, Kakeya H, Fujita M, Hasegawa K, Morimoto T. (2011). Innovative preparation of curcumin for improved oral bioavailability. Biol Pharm Bull, 34, 660–665.
  • Sikora E, Scapagnini G, Barbagallo M. (2010). Curcumin, inflammation, ageing and age-related diseases. Immun Ageing, 7, 1.
  • Sintov AC, Levy HV, Botner S. (2010). Systemic delivery of insulin via the nasal route using a new microemulsion system: In vitro and in vivo studies. J Control Release, 148, 168–176.
  • Tønnesen HH, Másson M, Loftsson T. (2002). Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability. Int J Pharm, 244, 127–135.
  • Uchida M, Katoh T, Mori M, Maeno T, Ohtake K, Kobayashi J, Morimoto Y, Natsume H. (2011). Intranasal administration of milnacipran in rats: evaluation of the transport of drugs to the systemic circulation and central nervous system and the pharmacological effect. Biol Pharm Bull, 34, 740–747.
  • Washington N, Steele RJ, Jackson SJ, Bush D, Mason J, Gill DA, Pitt K, Rawlins DA. (2000). Determination of baseline human nasal pH and the effect of intranasally administered buffers. Int J Pharm, 198, 139–146.
  • Wen MM. (2011). Olfactory targeting through intranasal delivery of biopharmaceutical drugs to the brain: current development. Discov Med, 11, 497–503.
  • Wen Z, Yan Z, Hu K, Pang Z, Cheng X, Guo L, Zhang Q, Jiang X, Fang L, Lai R. (2011). Odorranalectin-conjugated nanoparticles: preparation, brain delivery and pharmacodynamic study on Parkinson’s disease following intranasal administration. J Control Release, 151, 131–138.
  • Xia H, Gao X, Gu G, Liu Z, Zeng N, Hu Q, Song Q, Yao L, Pang Z, Jiang X, Chen J, Chen H. (2011). Low molecular weight protamine-functionalized nanoparticles for drug delivery to the brain after intranasal administration. Biomaterials, 32, 9888–9898.
  • Xie Y, Fan J, Ding P, Zhang B. (2011). In vitro release of nobiletin thermosensitive nasal in situ gel. Chinese J Pharm, 42, 189–192.
  • Yang JP, Liu HJ, Cheng SM, Wang ZL, Cheng X, Yu HX, Liu XF. (2009). Direct transport of VEGF from the nasal cavity to brain. Neurosci Lett, 449, 108–111.
  • Yin YM, Cui FD, Mu CF, Choi MK, Kim JS, Chung SJ, Shim CK, Kim DD. (2009). Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation. J Control Release, 140, 86–94.
  • Yu A, Wang H, Wang J, Cao F, Gao Y, Cui J, Zhai G. (2011). Formulation optimization and bioavailability after oral and nasal administration in rabbits of puerarin-loaded microemulsion. J Pharm Sci, 100, 933–941.
  • Zhang L, Wang X, Li W, Qiu X, Sun W, Hu G. (2011). Pharmacokinetics and absolute bioavailability of curcumin in rats. Chinese Pharmcol Bull, 27, 1458–1462.
  • Zhang Q, Jiang X, Jiang W, Lu W, Su L, Shi Z. (2004). Preparation of nimodipine-loaded microemulsions for intranasal delivery and evaluation on the targeting efficiency to the brain. Int J Pharm, 275, 85–96.
  • Zhu W, Yu A, Wang W, Dong R, Wu J, Zhai G. (2008). Formulation design of microemulsion for dermal delivery of penciclovir. Int J Pharm, 360, 184–190.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.